Literature DB >> 28803683

Tristan Mirault1, Henri Guillet2, Emmanuel Messas2.   

Abstract

Takayasu arteritis (TAK) is a vasculitis of the large arteries. The arterial wall, target of the immune reaction, is composed of vascular dendritic cells, endothelial cells, vascular smooth muscle cells and fibroblasts, which engage in an interaction with T cells and macrophages to, ultimately, cause luminal stenosis or aneurysmal wall damage of the vessel. A multitude of cytokines have been identified to increase in case of TAK and to be linked to disease activity. A better understanding of the physiopathological pathways and mechanisms involved, might enable a more tailored therapeutic approach in TAK.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28803683     DOI: 10.1016/j.lpm.2017.07.002

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

Review 1.  Takayasu Arteritis: Recent Developments.

Authors:  Maria L F Zaldivar Villon; Jose A Leon de la Rocha; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2019-07-18       Impact factor: 4.592

Review 2.  New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory.

Authors:  J Luis Espinoza; Suzue Ai; Itaru Matsumura
Journal:  Pathogens       Date:  2018-09-06

3.  Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis.

Authors:  Tomoyuki Mutoh; Tsuyoshi Shirai; Tomonori Ishii; Yuko Shirota; Fumiyoshi Fujishima; Fumiaki Takahashi; Yoichi Kakuta; Yoshitake Kanazawa; Atsushi Masamune; Yoshikatsu Saiki; Hideo Harigae; Hiroshi Fujii
Journal:  Nat Commun       Date:  2020-03-09       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.